Clinical Trial Update: Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ziprasidone for bipolar disorder with comorbid lifetime panic disorder or generalized anxiety disorder; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: VA Palo Alto Health Care System | Conditions: Bipolar Disorder, Panic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-04-08